{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T18:54:47Z","timestamp":1772909687497,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bioethical Inquiry"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11673-020-10030-x","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T13:03:51Z","timestamp":1598360631000},"page":"709-715","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Coronavirus Human Infection Challenge Studies: Assessing Potential Benefits and Risks"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5940-602X","authenticated-orcid":false,"given":"Euzebiusz","family":"Jamrozik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George S.","family":"Heriot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Selgelid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,25]]},"reference":[{"issue":"1","key":"10030_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/phe\/phv026","volume":"9","author":"B Bambery","year":"2015","unstructured":"Bambery, B., M. Selgelid, C. Weijer, J. Savulescu, and A.J. Pollard. 2015. Ethical criteria for human challenge studies in infectious diseases. Public Health Ethics 9(1): 92-103.","journal-title":"Public Health Ethics"},{"key":"10030_CR2","unstructured":"Bandaranayake, D., A. Bissielo, S. Huang, and T. Wood. 2010. Seroprevalence of the 2009 influenza A (H1N1) pandemic in New Zealand. Institute of Environemntal Science and Research Limited, National Centre for Biosecurity and Infectious Diseases, Client Report FW10057. https:\/\/www.health.govt.nz\/system\/files\/documents\/publications\/seroprevalence-flu-2009.pdf. Accessed August 10, 2020."},{"issue":"2","key":"10030_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1017\/S0950268800048019","volume":"105","author":"K Callow","year":"1990","unstructured":"Callow, K., H. Parry, M. Sergeant, and D. Tyrrell. 1990. The time course of the immune response to experimental coronavirus infection of man. Epidemiology & Infection 105(2): 435-446.","journal-title":"Epidemiology & Infection"},{"key":"10030_CR4","doi-asserted-by":"crossref","unstructured":"Cohen, J. 2020. Speed coronavirus vaccine testing by deliberately infecting volunteers? Not so fast, some scientists warn. Science Magazine, March 31. https:\/\/www.sciencemag.org\/news\/2020\/03\/speed-coronavirus-vaccine-testing-deliberately-infecting-volunteers-not-so-fast-some. Accessed August 10, 2020.","DOI":"10.1126\/science.abc0006"},{"key":"10030_CR5","unstructured":"Eyal, N., and M. Lipsitch. 2020. Ethical comparators in coronavirus vaccine trials. http:\/\/nrs.harvard.edu\/urn-3:HUL.InstRepos:42643064. Accessed August 10, 2020."},{"issue":"11","key":"10030_CR6","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1093\/infdis\/jiaa152","volume":"221","author":"N Eyal","year":"2020","unstructured":"Eyal, N., M. Lipsitch, and P.G. Smith. 2020. Human challenge studies to accelerate coronavirus vaccine licensure. Journal of Infectious Diseases 221(11): 1752-1756.","journal-title":"Journal of Infectious Diseases"},{"issue":"18","key":"10030_CR7","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1056\/NEJMp2003762","volume":"382","author":"B Gates","year":"2020","unstructured":"Gates, B. 2020. Responding to Covid-19\u2014A once-in-a-century pandemic? New England Journal of Medicine 382(18): 1677-1679.","journal-title":"New England Journal of Medicine"},{"key":"10030_CR8","doi-asserted-by":"crossref","unstructured":"Heriot, G.S., E. Jamrozik, and M.J. Selgelid. 2020. Tensions between public health and vaccine research priorities: A comparative modelling assessment of the risks and benefits of SARS-CoV-2 vaccine field trials versus human challenge studies.","DOI":"10.1101\/2020.05.18.20106187"},{"issue":"9","key":"10030_CR9","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1177\/014556139407300906","volume":"73","author":"DA Hilding","year":"1994","unstructured":"Hilding, D.A. 1994. Literature review: The common cold. Ear, Nose & Throat Journal 73(9): 639-647.","journal-title":"Ear, Nose & Throat Journal"},{"issue":"1","key":"10030_CR10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1136\/jme.2003.004440","volume":"30","author":"T Hope","year":"2004","unstructured":"Hope, T., and J. McMillan. 2004. Challenge studies of human volunteers: Ethical issues. Journal of Medical Ethics 30(1): 110-116.","journal-title":"Journal of Medical Ethics"},{"key":"10030_CR11","doi-asserted-by":"crossref","unstructured":"Jamrozik, E., and M.J. Selgelid. 2020a. Human challenge studies in endemic settings: Ethical and regulatory issues. Springer International Publishing.","DOI":"10.1007\/978-3-030-41480-1"},{"key":"10030_CR12","doi-asserted-by":"crossref","unstructured":"\u2014\u2014\u2014. 2020b. COVID19 human challenge studies: Ethical issues. Lancet Infectious Diseases 20(8): e198-e203.","DOI":"10.1016\/S1473-3099(20)30438-2"},{"key":"10030_CR13","unstructured":"\u2014\u2014\u2014. 2020c. Ethical issues surrounding controlled human infection challenge studies in endemic low-and middle-income countries. Bioethics."},{"issue":"10111","key":"10030_CR14","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","volume":"390","author":"C Jin","year":"2017","unstructured":"Jin, C., M.M. Gibani, M. Moore, et al. 2017. Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: A randomised controlled, phase 2b trial. The Lancet 390(10111): 2472-2480.","journal-title":"The Lancet"},{"issue":"2","key":"10030_CR15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/aje\/kwy239","volume":"188","author":"R Kahn","year":"2019","unstructured":"Kahn, R., M. Hitchings, R. Wang, S.E. Bellan, and M. Lipsitch. 2019. Analyzing vaccine trials in epidemics with mild and asymptomatic infection. American Journal of Epidemiology 188(2): 467-474.","journal-title":"American Journal of Epidemiology"},{"issue":"3","key":"10030_CR16","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/oxfordjournals.aje.a115516","volume":"131","author":"M Krzyzanowski","year":"1990","unstructured":"Krzyzanowski, M., D.L. Sherrill, and M.D. Lebowitz. 1990. Longitudinal analysis of the effects of acute lower respiratory illnesses on pulmonary function in an adult population. American Journal of Epidemiology 131(3): 412-422.","journal-title":"American Journal of Epidemiology"},{"key":"10030_CR17","doi-asserted-by":"crossref","unstructured":"Lederer, S.E. 2008. Walter Reed and the yellow fever experiments. In The Oxford textbook of clinical research ethics, edited by E.J. Emanuel, C.C. Grady, R.A. Crouch et al., 9-17. USA: Oxford University Press.","DOI":"10.1093\/oso\/9780195168655.003.0002"},{"key":"10030_CR18","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41591-020-0887-3","volume":"26","author":"M Lipsitch","year":"2020","unstructured":"Lipsitch, M., R. Kahn, and M.J. Mina. 2020. Antibody testing will enhance the power and accuracy of COVID-19-prevention trials. Nature Medicine 26: 818-819.","journal-title":"Nature Medicine"},{"issue":"21","key":"10030_CR19","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1056\/NEJMp2005630","volume":"382","author":"N Lurie","year":"2020","unstructured":"Lurie, N., M. Saville, R. Hatchett, and J. Halton. 2020. Developing COVID-19 vaccines at pandemic speed. New England Journal of Medicine 382(21): 1969-1973.","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10030_CR20","doi-asserted-by":"publisher","first-page":"e00417","DOI":"10.1128\/mBio.00417-16","volume":"7","author":"MJ Memoli","year":"2016","unstructured":"Memoli, M.J., P.A. Shaw, A. Han, et al. 2016. Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A\/H1N1 virus healthy human challenge model. MBio 7(2): e00417-e00416.","journal-title":"MBio"},{"key":"10030_CR21","volume-title":"National Statement on Ethical Conduct in Human Research","author":"National Health and Medical Research Council and Australian Research Council","year":"2018","unstructured":"National Health and Medical Research Council and Australian Research Council. 2018. National Statement on Ethical Conduct in Human Research. Canberra: Commonwealth of Australia."},{"issue":"10237","key":"10030_CR22","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/S0140-6736(20)31034-5","volume":"395","author":"AL Phelan","year":"2020","unstructured":"Phelan, A.L. 2020. COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges. The Lancet 395(10237): 1595-1598.","journal-title":"The Lancet"},{"issue":"24","key":"10030_CR23","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1016\/j.vaccine.2020.04.039","volume":"38","author":"SA Plotkin","year":"2020","unstructured":"Plotkin, S.A., and A. Caplan. 2020. Extraordinary diseases require extraordinary solutions. Vaccine 38(24): 3987.","journal-title":"Vaccine"},{"issue":"6500","key":"10030_CR24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1126\/science.abc3517","volume":"369","author":"H Salje","year":"2020","unstructured":"Salje, H., C.T. Kiem, N. Lefrancq, et al. 2020. Estimating the burden of SARS-CoV-2 in France. Science 369(6500): 208-211.","journal-title":"Science"},{"key":"10030_CR25","doi-asserted-by":"publisher","unstructured":"Schaefer, G., C.C. Tam, J. Savulescu, and T.C. Voo. 2020. Covid-19 vaccine development: Time to consider Sars-Cov-2 challenge studies? Doi: https:\/\/doi.org\/10.2139\/ssrn.3568981.","DOI":"10.2139\/ssrn.3568981"},{"key":"10030_CR26","unstructured":"Shah, S.K., J. Kimmelman, A.D. Lyerly, et al. 2017. Ethical considerations for Zika virus human challenge trials. National Institute of Allergy and Infectious Diseases."},{"issue":"12","key":"10030_CR27","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.1128\/IAI.67.12.6341-6345.1999","volume":"67","author":"CO Tacket","year":"1999","unstructured":"Tacket, C.O., M.B. Cohen, S.S. Wasserman, et al. 1999. Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination. Infection and immunity. 67(12): 6341-6345.","journal-title":"Infection and immunity."},{"issue":"6","key":"10030_CR28","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.vaccine.2018.12.040","volume":"37","author":"KS Vannice","year":"2019","unstructured":"Vannice, K.S., M.C. Cassetti, R.W. Eisinger, et al. 2019. Demonstrating vaccine effectiveness during a waning epidemic: A WHO\/NIH meeting report on approaches to development and licensure of Zika vaccine candidates. Vaccine 37(6): 863-868.","journal-title":"Vaccine"},{"issue":"6","key":"10030_CR29","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1473-3099(20)30243-7","volume":"20","author":"R Verity","year":"2020","unstructured":"Verity, R., L.C. Okell, I. Dorigatti, et al. 2020. Estimates of the severity of coronavirus disease 2019: A model-based analysis. The Lancet Infectious Diseases 20(6): 669-677.","journal-title":"The Lancet Infectious Diseases"},{"key":"10030_CR30","doi-asserted-by":"crossref","unstructured":"Wenner, D.M. 2018. Exploitation and international clinical research: The disconnect Between goals and policy. The Palgrave Handbook of Philosophy and Public Policy, edited by D. Boonin, 563-574. Palgrave Macmillan and Springer Nature.","DOI":"10.1007\/978-3-319-93907-0_43"},{"key":"10030_CR31","unstructured":"WHO Working Group for Guidance on Human Challenge Studies in COVID-19 2020. Key criteria for the ethical acceptability of COVID-19 human challenge studies. Geneva, Switzerland."}],"container-title":["Journal of Bioethical Inquiry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11673-020-10030-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11673-020-10030-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11673-020-10030-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T13:18:08Z","timestamp":1723468688000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11673-020-10030-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,25]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10030"],"URL":"https:\/\/doi.org\/10.1007\/s11673-020-10030-x","relation":{},"ISSN":["1176-7529","1872-4353"],"issn-type":[{"value":"1176-7529","type":"print"},{"value":"1872-4353","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,25]]},"assertion":[{"value":"18 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}